Category: Healthcare

logo gilead sciences 0

What Does Orphan Drug Approval For Gilead Sciences, Inc. (GILD)’s Simtuzumab Mean?

Gilead Sciences, Inc. (NASDAQ:GILD)’s monoclonal antibody Simtuzumab recently obtained orphan drug status as a treatment for a rare liver-related disorder – primary sclerosing cholangitis. The designation may provide Gilead increased patent protection and boast...

Lab 0

Have Biotech Stocks Topped Out?

Biotech stocks, especially the Big Pharma names, have had a tumultuous year in 2014. Most major biotech stocks have been hit with expiration of marketing exclusivity of blockbuster drugs, yet development of new potential...

doctor-and-patient 0

Top Five Healthcare Predictions For 2015

Healthcare has always assumed importance in the face of new drugs arrival, as well as, fresh disease emanating. Not to mention people are just interested in living longer! Therefore, what is in store for...